The PTeye system uses dye-free technology to detect autofluorescence of parathyroid tissue in real-time in the surgical suite. The system uses a console display and disposable probe. In addition, ...

Investors also possibly exercised caution in the face of Medtronic’s medical surgical revenue ... our long-term investments ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

"Medtronic launches Avalus Ultra surgical aortic tissue valve " was ... to industry to partner with them to deliver improved innovation to treat their patients efficiently and effectively.

Medtronic Plc is a medical technology company ... The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions.

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic’s diverse portfolio faces financial growth concerns. Learn why MDT stock is a HOLD, offering stability but limited growth in the short term.

This has potentially set the stage for stocks like Medtronic MDT to gain momentum ... banking Micra leadless pacemaker. Innovations and market expansion efforts are helping it offset the impact ...

According to a recent study by Report Ocean, the global surgical robotics market was valued at USD 5.8 billion in 2021 and is projected to grow at a CAGR of 18.40%, reaching approximately USD 18.2 ...